A
ABVC BioPharma, Inc. (ABVC)
NCM – Real Time Price. Currency in USD
1.00
-0.06 (-5.66%)
At close: Mar 27, 2026, 4:00 PM EDT
1.00
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
1.00
-0.06 (-5.66%)
At close: Mar 27, 2026, 4:00 PM EDT
1.00
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.
| Name | Position |
|---|---|
| Dr. Tsung-Shann Jiang EMBA, Ph.D. | Chief Scientific Officer, Chief Strategy Officer & Director |
| Dr. Uttam Yashwant Patil Ph.D. | CEO & Interim CFO |
| Mr. Eugene Jiang | Chairman & Chief Business Officer |
| Date | Type | Document |
|---|---|---|
| 2026-03-03 | 10-Q/A | ea0278312-10qa1_abvc.htm |
| 2026-01-16 | 8-K/A | ea0272768-8ka1_abvc.htm |
| 2025-11-03 | 8-K | ea0263481-8k_abvcbio.htm |
| 2025-10-30 | 8-K | ea0262960-8k_abvcbio.htm |
| 2025-09-12 | 8-K/A | ea0256995-8ka1_abvcbio.htm |
| 2025-08-14 | 8-K | ea0253086-8k_abvcbio.htm |
| 2025-08-13 | 10-Q | ea0251467-10q_abvcbio.htm |
| 2025-07-18 | 8-K/A | ea0249475-8ka_abvcbio.htm |
| 2025-06-27 | S-8 | ea0246580-s8_abvc.htm |
| 2025-06-04 | 8-K | ea024460401-8k_abvcbio.htm |